Meta Pixel

News and Announcements

Tesserent Limited (ASX:TNT) Secures $1m Contract and Launches Two New Services

  • Published July 11, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Tesserent is a specialist in managed cyber security. The company has announced to shareholder an update on key business matters following the closure of the FY2017.

KEY TAKEAWAYS:

  • Tesserent was cash flow positive in the June quarter.
  • The company secured $1.03M total contract value in new business during the quarter of June. The revenue made will be realised over the next 3 years.
  • During March, Tesserent began a restructure of the sales team. This process is still on-going, however changes within the business have already resulted positively on sales activity and revenue.
  • Tesserent, secure $530K TCV of new SIEM contracts during the quarter of June.
  • Tesserent was delighted to have been selected by the Australian Cyber Security Growth Network (ACSGN) to provide a managed SIEM service.
  • Tesserent continues to grow with product offerings, launching two new proprietary products during the June Quarter.
    • ‘CyberBIZ’ is a comprehensive SMB focused managed service offering.
    • ‘Portal Defence’ is a program which offers highly secure interface for web portal.

Tesserent CEO, Keith Glennan said:
“We are pleased to have finished the financial year with strong sales results, an expanding set of notable customers, and a continued focus on product development. Tesserent is not only continuing to provide world-class managed services to new and existing customers; we are leading the industry with innovative product development, cleverly defined to meet the emerging needs of the market.”

“We’ve all worked extremely hard to deliver this result during the June quarter, however importantly, we’ve also established a solid pipeline for the quarter ahead. We are focused on building upon this momentum and delivering further growth in the new financial year.”

Request Information

Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets

QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Join over 45,000+ sophisticated investors

Join Now